Leading the prescription omega-3 market
Pioneers in the development of prescription omega-3 substances
BASF pioneered the omega-3 pharma market by introducing, in 1994, Omacor®/Lovaza™ as the first prescription omega-3 drug with approval from the FDA/EU. We became world leaders in high-concentrate omega-3 fatty acids for pharmaceuticals.
In addition to our established & proven high-quality omega-3 product and service portfolio, we offer unrivalled experience and unique expertise in development and management of customized omega-3 solutions.
Proven, pure and potent omega-3 solutions.